![]() |
|
|||||||
| News / Research / Articles / Books Helpful resources for books, news, research and more. If you find a book article or research paper interesting, mention it here please. |
![]() |
|
|
Thread Tools |
|
|
#1 |
|
Join Date: Jul 2004
Location: Ontario, Canada
Posts: 11,473
|
Psychiatry Funding Questioned
To read the full article, please lick on link:
http://www.boston.com/news/local/mas...tioned?pg=full For the first time, Massachusetts General Hospital's renowned psychiatry department has accepted money from the pharmaceutical industry to educate doctors around the country. After decades of offering continuing medical education classes in Boston, Harvard Medical School teaching hospital last year raised $6.5 million from Cephalon Inc., Janssen Medical Affairs, GlaxoSmithKline, and Wyeth for its 2005 program. The pool of money will allow the psychiatry department to dramatically expand its continuing medical education program with live lectures in 24 cities, teleconferences, and around-the-clock webcasts. Mass. General psychiatrists said without outside funding they would have to charge doctors prohibitively high tuition. They said they have developed ways to minimize the risk that drug company money could bias classroom instruction. ''The companies don't have any input into the curriculum, and there is no ongoing dialogue throughout the year," said Dr. Robert Birnbaum, medical director of the Division of Postgraduate Education for the psychiatry department. ''We're hoping this becomes a national model." In recent years, the pharmaceutical industry has become increasingly interested in funding continuing medical education. While companies say their motive is to help educate doctors, the practice is raising concerns in the medical profession. Recently enacted rules have explicitly forbidden companies from nudging course content toward positive discussion of their drugs. But even those measures have not satisfied some critics.
__________________
On A/D's since 1995, switching due to side-effects on 30 different brands of TCA's, SSRI's, SNRI's, Antipsychotics, Benzo's & Imovane. 6 ECT's. Tapering from 225 mg Effexor XR May 17, 2004. (Equiv. to 60 mg Paxil) Last taper Effexor XR Jan 17, 2006 down to ZERO. Currently protracted withdrawal. Sept 2006: 25 mg Doxepin. March 13/09: 10 mg Desipramine |
|
|
|
|
|
#2 |
|
"has a lavender scented keyboard"
Join Date: Mar 2004
Location: Ontario
Posts: 22,214
|
Re: Psychiatry Funding Questioned
Absolutely disgusting to see it in writing, it is happening all over anyway, however to have it out in the open only acknowledges acceptance to this type of advertising AND controll from big pharm. Really makes me sick!
__________________
Rita |
|
|
|
|
|
#3 |
|
Administrator
Join Date: Feb 2004
Location: new jersey
Posts: 47,008
|
Re: Psychiatry Funding Questioned
''The companies don't have any input into the curriculum, and there is no ongoing dialogue throughout the year,"
Yup, and pigs fly!!
__________________
AKA Laurie "Faith is taking the first step even when you don't see the whole staircase." MLK |
|
|
|
|
|
#4 | |
|
Join Date: Jul 2004
Location: Ontario, Canada
Posts: 11,473
|
Re: Psychiatry Funding Questioned
Quote:
__________________
On A/D's since 1995, switching due to side-effects on 30 different brands of TCA's, SSRI's, SNRI's, Antipsychotics, Benzo's & Imovane. 6 ECT's. Tapering from 225 mg Effexor XR May 17, 2004. (Equiv. to 60 mg Paxil) Last taper Effexor XR Jan 17, 2006 down to ZERO. Currently protracted withdrawal. Sept 2006: 25 mg Doxepin. March 13/09: 10 mg Desipramine |
|
|
|
|
![]() |
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | |
|